BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10100133)

  • 1. Menstrual cycling and breast cancer: an evolutionary perspective.
    Strassmann BI
    J Womens Health; 1999 Mar; 8(2):193-202. PubMed ID: 10100133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of fecundability and conception waits among the Dogon of Mali.
    Strassmann BI; Warner JH
    Am J Phys Anthropol; 1998 Feb; 105(2):167-84. PubMed ID: 9511912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
    Hamerlynck JV; Vollebregt JA; Doornebos CM; Muntendam P
    Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of menstruation and its relevance to women's health.
    Harlow SD; Ephross SA
    Epidemiol Rev; 1995; 17(2):265-86. PubMed ID: 8654511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian function after the menarche and hormonal contraception.
    Borsos A; Lampé L; Balogh A; Csoknyay J; Ditròi F; Székely P
    Int J Gynaecol Obstet; 1988 Oct; 27(2):249-53. PubMed ID: 2903093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical rationale for menses-free contraception.
    Lin K; Barnhart K
    J Womens Health (Larchmt); 2007 Oct; 16(8):1171-80. PubMed ID: 17937570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age.
    Ferrell RJ; O'Connor KA; Rodríguez G; Gorrindo T; Holman DJ; Brindle E; Miller RC; Schechter DE; Korshalla L; Simon JA; Mansfield PK; Wood JW; Weinstein M
    Menopause; 2005; 12(5):567-77. PubMed ID: 16145311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive potential in the older woman.
    Gindoff PR; Jewelewicz R
    Fertil Steril; 1986 Dec; 46(6):989-1001. PubMed ID: 3536609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age at menarche, time to regular cycling, and breast cancer (North Carolina, United States).
    Rockhill B; Moorman PG; Newman B
    Cancer Causes Control; 1998 Aug; 9(4):447-53. PubMed ID: 9794178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communicating with patients about extended-cycle and continuous use of oral contraceptives.
    Nelson AL
    J Womens Health (Larchmt); 2007 May; 16(4):463-70. PubMed ID: 17521249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptothermal and hormonal markers of potential fertility in climacteric women.
    Flynn AM; James P; Collins WP; Royston P
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.
    Nappi RE; Fiala C; Chabbert-Buffet N; Häusler G; Jamin C; Lete I; Lukasiewic M; Pintiaux A; Lobo P
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):242-50. PubMed ID: 27010535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
    Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
    Milman N; Clausen J; Byg KE
    Ann Hematol; 1998; 77(1-2):13-9. PubMed ID: 9760147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.